showing 8794 abstracts from all years
filter abstracts
Details |
title |
year |
Details |
Construction and Pre-Clinical Evaluation of a New Anti-CD19 Chimeric Antige... |
2016 |
Details |
Impact of Additional Chromosomal Abnormalities in Philadelphia-Positive Clo... |
2016 |
Details |
Oral Vancomycin Is Highly Effective in Preventing Clostridium Difficile... |
2016 |
Details |
A Quantitative Assay of In Vivo Cleavage of Von Willebrand Factor ... |
2016 |
Details |
Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustr... |
2016 |
Details |
A Phase II Study Evaluating the Combination of Nivolumab (Nivo) or Ipilimum... |
2016 |
Details |
Stratified Intense-Dose- Yttrium-90 Ibritumumab Tiuxetan (90YIT ... |
2016 |
Details |
Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Devel... |
2016 |
Details |
Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose ... |
2016 |
Details |
a Phase I Trial of Bendamustine in Combination with Clofarabine and Etoposi... |
2016 |
Details |
Long-Term Safety of Dasatinib in Chinese Chronic Phase Chronic Myeloid Leuk... |
2016 |
Details |
Impact of Nutrition on Non-Relapse Mortality and Acute Graft Versus Host Di... |
2016 |
Details |
Nfe2 Is Dispensable for Early, but Required for Adult Thrombocyte Formation... |
2016 |
Details |
Clonal Hematopoiesis Increases Risk of Therapy-Related Myeloid Neoplasms... |
2016 |
Details |
Pembrolizumab, a PD-1 Inhibitor, in Patients with Myelodysplastic Syndrome ... |
2016 |
Details |
Fludarabine and Busulfan Plus Low Dose TBI Versus Cyclophosphamide Plus TBI... |
2016 |
Details |
Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cel... |
2016 |
Details |
Non-Invasive Multi-Modal Imaging to Evaluate Disease Severity in Sickle Cel... |
2016 |
Details |
Predictors of Delayed Clearance and Toxicities from High Dose Methotrexate ... |
2016 |
Details |
Correlation Between Treatment Outcomes, Baseline Characteristics and Molecu... |
2016 |
1 2 3 4 5 6 7 8 ...440 Next